Ossicodone E Naloxone Teva (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Ossicodone E Naloxone Teva, is an opioid analgesic presented as a combination tablet for oral use. It is indicated for the management of moderate to severe pain in adult patients. GNH USA supplies Ossicodone E Naloxone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ossicodone E Naloxone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ossicodone E Naloxone Teva combines an opioid agonist with an opioid antagonist to treat pain while reducing abuse potential.

- Acute postoperative pain: provides rapid analgesia after surgical procedures. - Chronic cancer‑related pain: maintains long‑term pain control in oncology patients. - Severe musculoskeletal pain: alleviates intense pain from conditions such as back injury or arthritis. - Breakthrough pain episodes: offers supplemental relief when baseline analgesia is insufficient. - Pain associated with palliative care: improves comfort in end‑of‑life settings.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting - Constipation - Dizziness or light‑headed dizziness - Drowsiness or somnol somd  t - Dry mouth - Sweat

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Allergic reactions such as anaphylaxis - Seizure  t - Hepatotoxic  t - QT  t -   t -  

When   g   ewline   ewline   ewline  ewline